Cordatus Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.99M Sell
8,245
-52
-0.6% -$17.8K 0.66% 48
2026
Q1
$2.92M Buy
8,297
+139
+2% +$49.6K 0.69% 46
2025
Q4
$2.67M Buy
8,158
+24
+0.3% +$7.61K 0.62% 51
2025
Q3
$2.3M Sell
8,134
-82
-1% -$23.8K 0.54% 57
2025
Q2
$2.29M Buy
8,216
+58
+0.7% +$16.4K 0.56% 52
2025
Q1
$2.54M Sell
8,158
-102
-1% -$30.1K 0.7% 48
2024
Q4
$2.15M Buy
+8,260
New +$2.45M 0.57% 58
2023
Q3
Sell
-8,580
Closed -$1.91M 67
2023
Q2
$1.91M Buy
+8,580
New +$1.99M 0.72% 49
2022
Q3
Sell
-7,939
Closed -$1.93M 67
2022
Q2
$1.93M Buy
7,939
+64
+0.8% +$15.7K 0.9% 41
2022
Q1
$1.9M Buy
7,875
+101
+1% +$23.2K 0.67% 55
2021
Q4
$1.75M Buy
+7,774
New +$1.64M 0.51% 78
2021
Q1
$1.72M Buy
6,930
+95
+1% +$22.7K 0.66% 63
2020
Q4
$1.57M Hold
6,835
0.66% 61
2020
Q3
$1.74M Sell
6,835
-53
-0.8% -$13.1K 0.84% 39
2020
Q2
$1.63M Buy
6,888
+46
+0.7% +$10.5K 0.89% 40
2020
Q1
$1.39M Buy
6,842
+1,814
+36% +$396K 1% 34
2019
Q4
$1.21M Buy
5,028
+740
+17% +$163K 0.6% 60
2019
Q3
$830K Buy
4,288
+462
+12% +$88.7K 0.43% 79
2019
Q2
$705K Buy
3,826
+151
+4% +$27K 0.41% 81
2019
Q1
$698K Buy
3,675
+333
+10% +$63.6K 0.38% 82
2018
Q4
$651K Buy
+3,342
New +$652K 0.46% 55

Other funds holding AMGN

Cordatus Wealth Management's AMGN Position: Q2 2026 in Review

Cordatus Wealth Management reduced its Amgen (AMGN) stake by 0.63% in Q2 2026, selling an estimated $17.8K and leaving 8,245 shares worth $2.99M. The position accounts for 0.66% of the portfolio, ranked #48.

Cordatus Wealth Management first reported a position in AMGN in Q4 2018 and has held it in 21 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Cordatus Wealth Management held 8,245 shares of Amgen worth $2.99M as of Q2 2026.
  • Cordatus Wealth Management sold 52 Amgen shares in Q2 2026, an estimated $17.8K.
  • Amgen made up 0.66% of Cordatus Wealth Management's portfolio in Q2 2026, its #48 holding.
  • Cordatus Wealth Management first reported a position in Amgen in Q4 2018 and has held it in 21 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Cordatus Wealth Management's 13F filing for Q2 2026, filed 29 Jul 2026.